Greater walking was associated with reduced severe fatigue at 6 and 12 months and improved quality of life at each follow-up, ...

A wife reflects on her husband’s cancer treatment, finding comfort, hope and connection in their simple ritual of sharing ...

A wife reflects on her husband’s cancer treatment, finding comfort, hope and connection in their simple ritual of sharing bagels before each treatment.

Mosunetuzumab’s 2022 approval introduced off-the-shelf T-cell redirection in follicular lymphoma, enabling faster initiation and broader site-of-care feasibility than individualized CAR-T ...

Therapeutic resistance after endocrine therapy and CDK4/6 inhibitors remains a key unmet need in metastatic ...

September is Blood Cancer Awareness Month, and recent weeks have brought major changes for people with blood cancers. In August, the FDA approved three treatments: Zenbexus (iberdomide) for relapsed ...

A genomic test led physicians to change extended endocrine therapy recommendations for 42% of people with early-stage HR-positive breast cancer. Results from the Breast Cancer Index (BCI) test led ...

Survivors and experts who have spoken with CURE share what to do before your first infusion, from saving your hair and protecting your skin to building a support team. The good news is that patients ...

Two sisters discover they share a BRCA2 mutation, but choose different paths to manage their breast cancer risk and navigate life as previvors.

FDA authorized belzutifan plus lenvatinib for advanced clear cell–component RCC following PD-1/PD-L1 inhibitor exposure, including progression during/after therapy or within six months of adjuvant ...

These seven breast cancer clinical trials are recruiting patients now, spanning early-stage, HR-positive, HER2-positive and triple-negative disease. For people newly diagnosed with breast cancer or ...

After 18 years of living with multiple myeloma, Sally Kalksma has learned that getting through cancer treatment is about more ...